INVO Bioscience, Inc. Annual Operating Income (Loss) in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
INVO Bioscience, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2023.
  • INVO Bioscience, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$1.9M, a 7.89% increase year-over-year.
  • INVO Bioscience, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$5.24M, a 45.5% increase year-over-year.
  • INVO Bioscience, Inc. annual Operating Income (Loss) for 2023 was -$6.77M, a 36.3% increase from 2022.
  • INVO Bioscience, Inc. annual Operating Income (Loss) for 2022 was -$10.6M, a 104% decline from 2021.
  • INVO Bioscience, Inc. annual Operating Income (Loss) for 2021 was -$5.22M, a 5.41% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$6.77M +$3.86M +36.3% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-04-17
2022 -$10.6M -$5.41M -104% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-04-17
2021 -$5.22M +$298K +5.41% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-17
2020 -$5.51M -$3.73M -208% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$1.79M +$846K +32.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-30
2018 -$2.63M -$1.99M -311% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 -$640K +$1.47M +69.7% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-16
2016 -$2.11M -$1.52M -255% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-29
2015 -$595K +$1.09M +64.6% Jan 1, 2015 Dec 31, 2015 10-K 2017-04-20
2014 -$1.68M -$1.08M -178% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-17
2013 -$605K -$52.9K -9.58% Jan 1, 2013 Dec 31, 2013 10-K 2017-03-17
2012 -$552K +$151K +21.5% Jan 1, 2012 Dec 31, 2012 10-K 2017-03-17
2011 -$703K Jan 1, 2011 Dec 31, 2011 10-K 2017-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.